Date Filed | Type | Description |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2023 |
4
| Makker Gotham (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Sold 10,312 shares
@ $21.0318, valued at
$216.9k
Sold 4,677 shares
@ $21.1383, valued at
$98.9k
|
|
08/21/2023 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Sold 1,534 shares
@ $15.471, valued at
$23.7k
|
|
08/21/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Sold 4,767 shares
@ $15.471, valued at
$73.8k
|
|
08/21/2023 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Sold 284 shares
@ $15.471, valued at
$4.4k
|
|
08/15/2023 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Exercised 725 restricted stock units
@ $0 |
|
08/15/2023 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Exercised 3,989 restricted stock units
@ $0 |
|
08/15/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Exercised 7,979 restricted stock units
@ $0 |
|
07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Sold 4,122 shares
@ $21.375, valued at
$88.1k
|
|
05/19/2023 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Sold 1,330 shares
@ $21.375, valued at
$28.4k
|
|
05/19/2023 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Sold 245 shares
@ $21.375, valued at
$5.2k
|
|
05/16/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Exercised 7,979 restricted stock units
@ $0 |
|
05/16/2023 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Exercised 725 restricted stock units
@ $0 |
|
05/16/2023 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Exercised 3,989 restricted stock units
@ $0 |
|
04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/05/2023 |
4
| RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Acquired 529,038 shares
@ $0 Acquired 1 options to buy
@ $40.0324, valued at
$40 Acquired 61,705 warrants
@ $65.23, valued at
$4M
|
|
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
02/22/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
02/22/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
02/22/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
12/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/11/2022 |
4
| RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Bought 1,355,932 shares
@ $14.75, valued at
$20M
|
|
08/16/2022 |
4
| Schwartz Jonathan David (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Granted 22,896 restricted stock units
@ $0 |
|
08/16/2022 |
4
| Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Granted 52,489 restricted stock units
@ $0 |
|
08/16/2022 |
4
| Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Granted 14,310 restricted stock units
@ $0 |
|
08/16/2022 |
4
| Wilson Martin (General Counsel) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Granted 20,318 options to buy
@ $17.47, valued at
$355k
Granted 28,763 restricted stock units
@ $0 |
|
06/15/2022 |
4
| Malik Fady Ibraham (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Granted 47,745 options to buy
@ $10.77, valued at
$514.2k
|
|
|